B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Kallidin

300 PubMed studies analyzed · 6 RCTs · Evidence Score: 44.4

Research Domains

Kallidin has been studied across 21 research domains including ❤️ Cardiovascular, 🔬 Inflammation, 🦴 Bone & Joint, 💊 Pain, 🔬 Oncology. The primary research focus is ❤️ Cardiovascular with 13% of studies addressing this area.

Loading evidence profile...

This evidence profile for Kallidin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.